Business
NeuroOne(R) Appoints Jason Mills to the Board of Directors
Veteran Med-Tech Research Analyst & Public Company Executive to Bring Strategic Experience, Industry Relationships and Vision to the Board EDEN PRAIRIE, MINN. - December 22, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq:...
About this update from Neuroone Medical Technologies Corporation
[{"type":"image","caption":"","headline":"NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time","size":{"original":{"width":140,"height":70,"url":"https://media.zenfs.com/en/newsmediawire_165/6e29368af07e7c003454bc6560423ba4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/61CM7UIIJoR34ZjwWwyL7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEwNTtjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/6e29368af07e7c003454bc6560423ba4","width":140,"height":70}}},{"type":"text","content":"Veteran Med-Tech Research Analyst & Public Company Executive to Bring Strategic Experience, Industry Relationships and Vision to the Board","length":142,"tagName":"p"},{"type":"text","content":"EDEN PRAIRIE, MINN. - December 22, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced the appointment of Jason Mills to its Board of Directors, effective as of December 18, 2025.","length":392,"tagName":"p"},{"type":"text","content":"Jason Mills currently serves as Executive Vice President of Strategy at NYSE-listed Penumbra, Inc., leading long-range planning, FP&A, Business Development, and Investor Relations. Penumbra is the world's leading thrombectomy company, focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Prior to joining Penumbra, he was a dedicated med-tech investment analyst for more than two decades. Mr. Mills held the role of Managing Director and head of the medical technology equity research practice at Canaccord Genuity for over 13 years, where he prepared financial models and financial forecasts, published research, and conducted due diligence on dozens of public and private companies in the sector. He has earned awards for his equity research, including the #2 ranked Medical Devices analyst in The Wall Street Journal's 2011 Best on the Street' Survey and #1 in the Medical Products segment of Forbes 2010 Best Brokerage Analysts. He holds a BA in Economics from Yale University and Masters in Sports Administration from Ohio University.","le...